<span item_type="fundamental" item_id="82afd8fd63cabe9542114e04c46fcbc8" counter_id="ST/US/CCLDO" env="prod"></span><span item_type="announcement" item_id="579904243168642561" env="prod"></span><p>Revenue: As of FY2025 Q3, the actual value is USD 31.07 M.</p><p>EPS: As of FY2025 Q3, the actual value is USD 0.04.</p><p>EBIT: As of FY2025 Q3, the actual value is USD 3.262 M.</p><p></p><h3>Healthcare IT Segment</h3><h4>Net Revenue</h4><ul><li>$75.6 million for the nine months ended September 30, 2025</li><li>$26.8 million for the three months ended September 30, 2025</li></ul><h4>Operating Expenses</h4><ul><li>Direct Operating Costs: $37.9 million for the nine months ended September 30, 2025</li><li>Selling and Marketing: $3.4 million for the nine months ended September 30, 2025</li><li>General and Administrative: $7.4 million for the nine months ended September 30, 2025</li><li>Research and Development: $3.8 million for the nine months ended September 30, 2025</li><li>Depreciation and Amortization: $10.5 million for the nine months ended September 30, 2025</li><li>Restructuring Costs: $154,000 for the nine months ended September 30, 2025</li></ul><h4>Operating Income</h4><ul><li>$12.4 million for the nine months ended September 30, 2025</li><li>$4.2 million for the three months ended September 30, 2025</li></ul><h3>Medical Practice Management Segment</h3><h4>Net Revenue</h4><ul><li>$10.5 million for the nine months ended September 30, 2025</li><li>$4.2 million for the three months ended September 30, 2025</li></ul><h4>Operating Expenses</h4><ul><li>Direct Operating Costs: $8.3 million for the nine months ended September 30, 2025</li><li>Selling and Marketing: $22,000 for the nine months ended September 30, 2025</li><li>General and Administrative: $1.9 million for the nine months ended September 30, 2025</li><li>Depreciation and Amortization: $246,000 for the nine months ended September 30, 2025</li></ul><h4>Operating Income</h4><ul><li>$123,000 for the nine months ended September 30, 2025</li><li>$502,000 for the three months ended September 30, 2025</li></ul><h3>Consolidated Metrics</h3><h4>Total Net Revenue</h4><ul><li>$86.1 million for the nine months ended September 30, 2025</li><li>$31.1 million for the three months ended September 30, 2025</li></ul><h4>Total Operating Expenses</h4><ul><li>$77.9 million for the nine months ended September 30, 2025</li><li>$27.9 million for the three months ended September 30, 2025</li></ul><h4>Operating Income</h4><ul><li>$8.2 million for the nine months ended September 30, 2025</li><li>$3.2 million for the three months ended September 30, 2025</li></ul><h4>Net Income</h4><ul><li>$7.9 million for the nine months ended September 30, 2025</li><li>$3.1 million for the three months ended September 30, 2025</li></ul><h3>Cash Flow</h3><h4>Operating Cash Flow</h4><ul><li>$19.9 million for the nine months ended September 30, 2025</li></ul><h4>Free Cash Flow</h4><ul><li>Net cash used in investing activities: - $21.2 million for the nine months ended September 30, 2025</li></ul><h3>Future Outlook and Strategy</h3><h4>Core Business Focus</h4><ul><li>The company plans to continue enhancing its liquidity and financial position by managing expenses and growing revenue. Management expects these efforts to improve profitability and overall financial health.</li></ul><h4>Non-Core Business</h4><ul><li>The company acquired MAP App, a hospital benchmarking tool, and created a new subsidiary, N884AM Holdings, Inc., for purchasing an aircraft to visit current and prospective clients.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1582982/000149315225021079/form10-q.htm"></span></li></ul>

Carecloud Pref Share CCLDO 8.75 Prep 02/15/24 B | 10-Q: FY2025 Q3 Revenue: USD 31.07 M